Wilfong Diane E. 4
4 · GILEAD SCIENCES, INC. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
Wilfong Diane E
Interim Corp Controller & CAO
Transactions
- Exercise/Conversion
Common Stock
2022-12-10+318→ 28,651 total - Exercise/Conversion
Restricted Stock Unit
2022-12-10−318→ 12,924 total→ Common Stock (318 underlying) - Tax Payment
Common Stock
2022-12-10$87.97/sh−149$13,108→ 28,502 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.